Testicular cancer overview

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2], Shanshan Cen, M.D. [3]

Testicular cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Testicular cancer overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer overview

CDC on Testicular cancer overview

Testicular cancer overview in the news

Blogs on Testicular cancer overview

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer overview

Overview

Testicular cancer is cancer that develops in the testicles, a part of the male reproductive system. Testicular cancer may be classified according to cell types into two subtypes: germ cell tumors and non–germ cell tumors.Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele. The prevalence of testicular cancer is approximately 88.1 per 100,000 males in the United States. The incidence of testicular cancer is approximately 5.88 per 100,000 males in the United States. Common risk factors in the development of testicular cancer are undescended testicle, family history, personal history of testicular cancer, Klinefelter syndrome.The most common symptoms of testicular cancer include a painless lump in the testicle, swelling of the testicle, and weight loss. An elevated concentration of blood tumor marker tests is diagnostic of testicular cancer. The predominant therapy for testicular cancer is surgical resection. Adjunctive chemotherapy and radiation therapy may be required. Prognosis of testicular cancer is generally good, and the 5-year survival rate is approximately 96.6%.

Classification

Testicular cancer may be classified according to cell types into two subtypes: germ cell tumors and non–germ cell tumors.

Pathophysiology

On microscopic histopathological analysis of testicular cancer, fried-egg appearance is the characteristic finding of seminoma; marked nuclear atypia is the characteristic finding of embryonal carcinoma; blander cytomorphology, hyaline-type globules, and Schiller-Duval bodies are characteristic findings of yolk sac tumor ; syncytiotrophoblasts and cytotrophoblast cells are the characteristic findings of choriocarcinoma.

Causes

There are no known direct causes for testicular cancer.

Differential Diagnosis

Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele.

Epidemiology and Demographics

The prevalence of testicular cancer is approximately 88.1 per 100,000 males in the United States. The incidence of testicular cancer is approximately 5.88 per 100,000 males in the United States. The majority of cases are reported in New Zealand. Testicular cancer usually affects males of the white race. African American individuals are less likely to develop testicular cancer.

Risk Factors

Common risk factors in the development of testicular cancer are undescended testicle, family history, personal history of testicular cancer, Klinefelter syndrome.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for testicular cancer.<ref>testicular Cancer. U.S. Preventive Service Task Force (USPSTF) 2015.

Prognosis

Prognosis of testicular cancer is generally good, and the 5-year survival rate is approximately 96.6%.

Staging

Testicular cancer may be classified into several subtypes based on TNM system and the American Joint Committee on Cancer (AJCC).

History and Symptoms

The most common symptoms of testicular cancer include a painless lump in the testicle, swelling of the testicle, and weight loss.

Physical Examination

Common physical examination findings of testicular cancer include weight loss, swelling of the testicle , and a painless mass in the testicle.

Laboratory Findings

An elevated concentration of blood tumor marker tests is diagnostic of testicular cancer.

X Ray

There are no X-ray findings associated with testicular cancer.

CT Scan

CT scan may be helpful in the diagnosis of testicular cancer.

MRI

MRI may be helpful in the diagnosis of testicular cancer.

Ultrasound

Ultrasound may be helpful in the diagnosis of testicular cancer.

Other Imaging Findings

There are no other imaging findings associated with testicular cancer.

Other Diagnostic Findings

There are no other diagnostic findings associated with testicular cancer.

Biopsy

Biopsy is rarely done in the diagnosis of testicular cancer.

Medical Therapy

The predominant therapy for testicular cancer is surgical resection. Adjunctive chemotherapy and radiation therapy may be required.

Surgery

Surgery is the mainstay of treatment for testicular cancer.

Primary Prevention

Effective measures for the primary prevention of testicular cancer include healthy lifestyle and monthly testicular self-exams.

Secondary Prevention

There are no secondary preventive measures available for testicular cancer.

References


Template:WikiDoc Sources